Organism name | Momordica charantia |
---|---|
Genus | Momordica |
Family | Cucurbitaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Momordica charantia |
---|---|
Linked NCBI taxonomy ID | 3673 |
Linked level | species |
Family in NCBI taxonomy | Cucurbitaceae |
---|---|
ID | 3650 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00023770
![]() |
Sitosterol
/ Stigmasta-5,22-dien-3beta-ol / (24R)24-Ethylcholesta-5,22-dien-3beta-ol |
CHEMBL221542
CHEMBL1398443 CHEMBL1875388 |
17 / 19 / 12 | No. 53 | No. 11 |
![]() |
||
C00000911
![]() |
Lycopene
/ all-trans-Lycopene |
CHEMBL501174
CHEMBL1984187 |
C015329
|
6 / 13 / 13 | 84 / 13 | No. 97 | No. 59 |
![]() |
C00048463
![]() |
Kuguacin N
/ (-)-Kuguacin N |
No. 119 | No. 51 |
![]() |
||||
C00048459
![]() |
Kuguacin J
|
No. 119 | No. 51 |
![]() |
||||
C00034061
![]() |
Momordicine I
/ (+)-Momordicine I |
No. 119 | No. 51 |
![]() |
||||
C00038733
![]() |
Charantoside III
/ (-)-Charantoside III |
CHEMBL409789
CHEMBL409790 |
No. 202 |
![]() |
||||
C00038736
![]() |
Charantoside VI
/ (-)-Charantoside VI |
CHEMBL266062
CHEMBL400981 |
No. 202 |
![]() |
||||
C00038735
![]() |
Charantoside V
/ (-)-Charantoside V |
CHEMBL266062
CHEMBL400981 |
No. 202 |
![]() |
||||
C00038738
![]() |
Charantoside VIII
/ (+)-Charantoside VIII |
CHEMBL400959
|
No. 202 |
![]() |
||||
C00038734
![]() |
Charantoside IV
/ (-)-Charantoside IV |
CHEMBL409789
CHEMBL409790 |
No. 202 |
![]() |
||||
C00038737
![]() |
Charantoside VII
/ (-)-Charantoside VII |
CHEMBL251068
|
No. 202 |
![]() |
||||
C00048468
![]() |
Kuguacin S
/ (-)-Kuguacin S |
No. 1475 |
![]() |
|||||
C00048464
![]() |
Kuguacin O
/ (-)-Kuguacin O |
No. 1475 |
![]() |
|||||
C00048458
![]() |
Kuguacin H
/ (-)-Kuguacin H |
No. 1475 |
![]() |
|||||
C00034003
![]() |
Kuguacin D
|
No. 1475 |
![]() |
|||||
C00034002
![]() |
Kuguacin C
/ (+)-Kuguacin C |
No. 1475 |
![]() |
|||||
C00034001
![]() |
Kuguacin B
/ (+)-Kuguacin B |
No. 1475 |
![]() |
|||||
C00034000
![]() |
Kuguacin A
|
No. 1475 |
![]() |
|||||
C00038089
![]() |
(19R,23E)-5beta,19-Epoxy-19-methoxycucurbita-6,23,25-trien-3beta-ol
|
CHEMBL249658
|
No. 1478 |
![]() |
||||
C00038088
![]() |
(19R,23E)-5beta,19-Epoxy-19,25-dimethoxycucurbita-6,23-dien-3beta-ol
|
CHEMBL398562
|
No. 1478 |
![]() |
||||
C00048450
![]() |
Karavilagenin D
/ (-)-Karavilagenin D |
No. 1478 |
![]() |
|||||
C00029557
![]() |
5beta,19-Epoxy-19-methoxycucurbita-6,23-diene-3beta,25-diol
/ 19(R)-Methoxy-5beta,19-epoxycucurbita-6,23-dien-3beta,25-diol / 5beta,19-Epoxy-19-methoxycucurbita-6,23(E)-diene-3beta,25-diol |
CHEMBL252510
|
No. 1478 |
![]() |
||||
C00048467
![]() |
Kuguacin R
/ (-)-Kuguacin R |
No. 1478 |
![]() |
|||||
C00048460
![]() |
Kuguacin K
/ (-)-Kuguacin K |
No. 1581 |
![]() |
|||||
C00048466
![]() |
Kuguacin Q
/ (-)-Kuguacin Q |
No. 1581 |
![]() |
|||||
C00034004
![]() |
Kuguacin E
/ (+)-Kuguacin E |
No. 1581 |
![]() |
|||||
C00048457
![]() |
Kuguacin G
/ (-)-Kuguacin G |
No. 1581 |
![]() |
|||||
C00048465
![]() |
Kuguacin P
/ (-)-Kuguacin P |
No. 1581 |
![]() |
|||||
C00048456
![]() |
Kuguacin F
/ (-)-Kuguacin F |
No. 1581 |
![]() |
|||||
C00048461
![]() |
Kuguacin L
/ (-)-Kuguacin L |
No. 3965 |
![]() |
|||||
C00048462
![]() |
Kuguacin M
/ (-)-Kuguacin M |
No. 3965 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00023770 | 1 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00023770 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00023770 | 2 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00023770 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00000911 | 11 / 10 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00023770 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00023770 | 3 / 2 |
P08183 | Multidrug resistance protein 1 | drug | C00023770 | 1 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00023770 | 0 / 1 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000911 | 2 / 3 |
O75496 | Geminin | Unclassified protein | C00000911 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00023770 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000911 | 0 / 0 |
P00734 | Prothrombin | S1A | C00023770 | 4 / 2 |
P14679 | Tyrosinase | Oxidoreductase | C00023770 | 4 / 2 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00023770 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00023770 | 1 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00023770 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00023770 | 0 / 1 |
P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00023770 | 1 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00000911 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000911 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00023770 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
118 | ADD1, ADDA | adducin 1 (alpha) |
C00000911
|
177 | AGER, RAGE | advanced glycosylation end product-specific receptor |
C00000911
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000911
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000911
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00000911
|
571 | BACH1, BACH-1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
C00000911
|
8314 | BAP1, HUCEP-13, UCHL2 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) (EC:3.4.19.12) |
C00000911
|
673 | BRAF, B-RAF1, BRAF1, NS7, RAFB1 | v-raf murine sarcoma viral oncogene homolog B (EC:2.7.11.1) |
C00000911
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000911
|
847 | CAT | catalase (EC:1.11.1.6) |
C00000911
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00000911
|
898 | CCNE1, CCNE | cyclin E1 |
C00000911
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00000911
|
1020 | CDK5, PSSALRE | cyclin-dependent kinase 5 (EC:2.7.11.22) |
C00000911
|
1022 | CDK7, CAK1, CDKN7, HCAK, MO15, STK1, p39MO15 | cyclin-dependent kinase 7 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
1025 | CDK9, C-2k, CDC2L4, CTK1, PITALRE, TAK | cyclin-dependent kinase 9 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000911
|
1113 | CHGA, CGA | chromogranin A (parathyroid secretory protein 1) |
C00000911
|
1114 | CHGB, SCG1 | chromogranin B (secretogranin 1) |
C00000911
|
23418 | CRB1, LCA8, RP12 | crumbs homolog 1 (Drosophila) |
C00000911
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00000911
|
1643 | DDB2, DDBB, UV-DDB2 | damage-specific DNA binding protein 2, 48kDa |
C00000911
|
1981 | EIF4G1, EIF-4G1, EIF4F, EIF4G, EIF4GI, P220, PARK18 | eukaryotic translation initiation factor 4 gamma, 1 |
C00000911
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000911
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000911
|
2176 | FANCC, FA3, FAC, FACC | Fanconi anemia, complementation group C |
C00000911
|
2188 | FANCF, FAF | Fanconi anemia, complementation group F |
C00000911
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00000911
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00000911
|
2701 | GJA4, CX37 | gap junction protein, alpha 4, 37kDa |
C00000911
|
2702 | GJA5, ATFB11, CX40 | gap junction protein, alpha 5, 40kDa |
C00000911
|
2879 | GPX4, GPx-4, GSHPx-4, MCSP, PHGPx, snGPx, snPHGPx | glutathione peroxidase 4 (EC:1.11.1.12) |
C00000911
|
3146 | HMGB1, HMG1, HMG3, SBP-1 | high mobility group box 1 |
C00000911
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00000911
|
3479 | IGF1, IGF-I, IGF1A, IGFI | insulin-like growth factor 1 (somatomedin C) |
C00000911
|
3480 | IGF1R, CD221, IGFIR, IGFR, JTK13 | insulin-like growth factor 1 receptor (EC:2.7.10.1) |
C00000911
|
3485 | IGFBP2, IBP2, IGF-BP53 | insulin-like growth factor binding protein 2, 36kDa |
C00000911
|
3713 | IVL | involucrin |
C00000911
|
3716 | JAK1, JAK1A, JAK1B, JTK3 | Janus kinase 1 (EC:2.7.10.2) |
C00000911
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00000911
|
3796 | KIF2A, CDCBM3, HK2, KIF2 | kinesin heavy chain member 2A |
C00000911
|
3838 | KPNA2, IPOA1, QIP2, RCH1, SRP1alpha | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) |
C00000911
|
3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00000911
|
3988 | LIPA, CESD, LAL | lipase A, lysosomal acid, cholesterol esterase (EC:3.1.1.13) |
C00000911
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00000911
|
5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00000911
|
6416 | MAP2K4, JNKK, JNKK1, MAPKK4, MEK4, MKK4, PRKMK4, SAPKK-1, SAPKK1, SEK1, SERK1, SKK1 | mitogen-activated protein kinase kinase 4 (EC:2.7.12.2) |
C00000911
|
5608 | MAP2K6, MAPKK6, MEK6, MKK6, PRKMK6, SAPKK-3, SAPKK3 | mitogen-activated protein kinase kinase 6 (EC:2.7.12.2) |
C00000911
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00000911
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000911
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00000911
|
4247 | MGAT2, CDG2A, CDGS2, GLCNACTII, GNT-II, GNT2 | mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.143) |
C00000911
|
100507436 | MICA, MIC-A, PERB11.1 | MHC class I polypeptide-related sequence A |
C00000911
|
4292 | MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1 | mutL homolog 1 |
C00000911
|
4436 | MSH2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2 | mutS homolog 2 |
C00000911
|
2956 | MSH6, GTBP, GTMBP, HNPCC5, HSAP, p160 | mutS homolog 6 |
C00000911
|
4842 | NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS | nitric oxide synthase 1 (neuronal) (EC:1.14.13.39) |
C00000911
|
8021 | NUP214, CAIN, CAN, D9S46E, N214, p250 | nucleoporin 214kDa |
C00000911
|
5320 | PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2 | phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) |
C00000911
|
5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) |
C00000911
|
10111 | RAD50, NBSLD, RAD502, hRad50 | RAD50 homolog (S. cerevisiae) |
C00000911
|
8045 | RASSF7, C11orf13, HRAS1, HRC1 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
C00000911
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00000911
|
5962 | RDX, DFNB24 | radixin |
C00000911
|
6195 | RPS6KA1, HU-1, MAPKAPK1A, RSK, RSK1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 (EC:2.7.11.1) |
C00000911
|
6197 | RPS6KA3, CLS, HU-3, ISPK-1, MAPKAPK1B, MRX19, RSK, RSK2, S6K-alpha3, p90-RSK2, pp90RSK2 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 (EC:2.7.11.1) |
C00000911
|
6241 | RRM2, R2, RR2, RR2M | ribonucleotide reductase M2 (EC:1.17.4.1) |
C00000911
|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00000911
|
6414 | SEPP1, SELP, SeP | selenoprotein P, plasma, 1 |
C00000911
|
4088 | SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3 | SMAD family member 3 |
C00000911
|
8243 | SMC1A, CDLS2, DXS423E, SB1.8, SMC1, SMC1L1, SMC1alpha, SMCB | structural maintenance of chromosomes 1A |
C00000911
|
6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00000911
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00000911
|
7980 | TFPI2, PP5, REF1, TFPI-2 | tissue factor pathway inhibitor 2 |
C00000911
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00000911
|
7097 | TLR2, CD282, TIL4 | toll-like receptor 2 |
C00000911
|
7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00000911
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000911
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000911
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00000911
|
7415 | VCP, ALS14, IBMPFD, IBMPFD1, TERA, p97 | valosin containing protein (EC:3.6.4.6) |
C00000911
|
7485 | WRB, CHD5 | tryptophan rich basic protein |
C00000911
|
7697 | ZNF138, pHZ-32 | zinc finger protein 138 |
C00000911
|
OMIM | preferred title | UniProt |
---|---|---|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#218030 | Apparent mineralocorticoid excess; ame |
P80365
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615363 | Estrogen resistance; estrr |
P03372
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601367 | Stroke, ischemic |
P00734
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
KEGG | name | UniProt |
---|---|---|
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D056486 | Drug-Induced Liver Injury |
C00000911
|
D006943 | Hyperglycemia |
C00000911
|
D006965 | Hyperplasia |
C00000911
|
D007248 | Infertility, Male |
C00000911
|
D007249 | Inflammation |
C00000911
|
D007674 | Kidney Diseases |
C00000911
|
D009369 | Neoplasms |
C00000911
|
D020258 | Neurotoxicity Syndromes |
C00000911
|
D011471 | Prostatic Neoplasms |
C00000911
|
D012878 | Skin Neoplasms |
C00000911
|
D013733 | Testicular Diseases |
C00000911
|
D014178 | Translocation, Genetic |
C00000911
|
D015431 | Weight Loss |
C00000911
|